期刊文献+

藏药帕珠丸对慢性酒精性肝损伤大鼠肝组织IL-1、IL-6、TNF-α、TGF-β_1含量及TGF-β_1 mRNA表达的影响 被引量:3

INFLUENCE OF PAZHUWAN ON THE LEVELS OF IL-1,IL-6,TNF-α,TGF-β_1 AND THE TGF-β_1 mRNA EXPRESSION IN LIVER WITH ALCOHOLIC LIVER DISEASE
下载PDF
导出
摘要 目的观察藏药帕珠丸对酒精性肝损伤大鼠肝组织IL-1、IL-6、TNF-α、TGF-β1含量及TGF-β1mRNA表达的影响。方法分别给予慢性酒精性肝损伤模型大鼠50、100、200 mg·kg-1帕珠丸混悬液,观察其对肝组织IL-1、IL-6、TNF-α、TGF-β1含量及TGF-β1mRNA表达的影响。结果藏药帕珠丸低、中、高剂量组肝组织IL-1、IL-6、TNF-α、TGF-β1含量均显著降低(P<0.05),TGF-β1mRNA表达下降(P<0.05)。结论藏药帕珠丸可能是通过降低肝组织中IL-1、IL-6、TNF-α、TGF-β1含量及TGF-β1mRNA表达,对大鼠慢性酒精性肝损伤发挥保肝作用。 Objective To observe the effects of Pazhuwan on the levels of IL - 1, IL -6, TNF - α, TGF - β1 and the mRNA expression of TGF - β1 in Rat hepatic tissue with alcoholic liver disease (ALD). Methods ALD model was established by feeding SD male rats with alcoholic,Pazhuwan (50,100, 200 mg · kg^-1) was orally administrated to experiment groups of rats. The IL- 1, IL- 6 ,TNF- α, TGF- β1 levels and the mRNA expression of TGF - β1 in hepatic tissue were tested. Results The levels of IL - 1, IL - 6, TNF - α, TGF - β1 in the Pazhuwan group were significantly decreased ( P 〈 0. 05 ). The same changes were observed in the mRNA expression of TGF -β1 in hepatic tissue. Conclusion Pazhuwan is likely to protecting the chronic alcoholic injury liver by inhibition inflammation cytokines levels.
出处 《青海医学院学报》 CAS 2014年第2期119-122,共4页 Journal of Qinghai Medical College
基金 青海省自然科学基金项目(2012-Z-709)
关键词 帕珠丸 酒精性肝损伤 白介素-1 白介素-6 肿瘤坏死因子-α 转化生长因子β1 Pazhuwan Alcoholic liver disease IL-1 IL-6 TNF-α TGF-β1
  • 相关文献

参考文献8

二级参考文献41

  • 1张晓岚,王占魁,姜慧卿.氧化应激与肝纤维化[J].临床肝胆病杂志,2007,23(3):226-229. 被引量:24
  • 2孟民杰,杨钦河,王强,陈雪梅,王凤珍,王彦平,唐海兰,程少冰,凌家生,温承远,谢芳.不同治法方药对大鼠脂肪肝Kupffer细胞ERK1/2蛋白活性的影响[J].中国病理生理杂志,2007,23(8):1551-1555. 被引量:26
  • 3曹丽香,董梅,高冬花,胡培谦,王宽鑫,梁波.重度创伤病人监测血清TNF-α及CRP水平与预后的关系初探[J].大理学院学报(综合版),2007,6(8):23-24. 被引量:1
  • 4GREENFIELD V, CHEUNG O, SANYAL A J. Recent advances in nonalcoholic fatty liver disease [ J ]. Curr Opin Gastroenterol, 2008,2d (3) :320 - 327.
  • 5FARRELL G C, LARTER C Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis [ J ]. Hepatology, 2006,43(2 Suppl 1 ):$99- Sl12.
  • 6CLARK J M, DIEHL A M. Defining nonalocolic fatty liv- er disease: implications for epidemiologic studies [ J ]. Gastroenterology, 2003,124( 1 ) : 248 - 250.
  • 7HUBSCHER S G. Histological assessment of non-alcohol- ic fatty liver disease [ J ]. Histopathology, 2006,49 (5) : 450 - 465.
  • 8CRAIG J, SH IRISH B, ION D, et al. Cytokines in alco- holic liver disease [ J]. Semin Liver Dis, 1999, 19(2) : 205 -219.
  • 9MCELAIN C J, MOKSHAGUNDAM S P, BARVE S S, et al. Mechanisms of non-alcoholic steatohepatitis [ J ] . Alcohol, 2004, 34( 1 ) :67 -79.
  • 10CHOI S, DIEHL A M. Role of inflammation in nonalco- holic steatohepatitis[ J]. Curr Opin Gastroenterol, 2005, 21(6) : 702 -707.

共引文献144

同被引文献63

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部